Blue Horseshoe Stocks: NLNK Recap & More

NewLink Genetics Corp. NLNK

After our call of NLNK Thursday morning, the stock traded from 9.50-14.48 (+52%) which was a fantastic move for something it that price range.  We noted the strong close, and Friday morning re-iterated our interest despite the big move we’d already witnessed.

It’s a good thing we left NLNK on our radars, because while it didn’t quite rise to the previous session’s intraday performance, it came awfully close, and completed a very nice two-day swing for us in the process. Friday’s trading range on NLNK ran from 13.51 up to a new high of 19.30 for a daily move of 43% and representing a two-session rise of 103%

The stock traded thirteen times its monthly average volume, and maintained well over half its advance into a second consecutive strong close, so we’re quite curious to monitor its activity as we kick off a fresh trading week.


Kura Oncology Inc. KURA

Speaking of higher-priced movers, we also tagged KURA in Friday’s premarket report after the company’s mid-stage cancer treatment trials yielded positive results. It too went on a run which was uncharacteristically volatile for a $9+ stock.

The tradin grange on this one ran from 9.30-13.80 for an intraday push of 48% and did so on over 20X the monthly average volume. The close wasn’t quite as strong as the previously mentioned play, but we’ll still leave a slot open on our radar screens for KURA heading into this week.

______

Honorable Mention: Adaptimmune Therapeutics plc ADAP – While the level of gains provided wasn’t quite as high following our tag of ADAP on Thursday, the stock did string together a noteworthy couple of sessions. It traded from a low of 7.02 on Thursday to a high of 8.95 on Friday, marking a 27% swing.


Extended Watchlist:
MRNS, TEVA, BSMX, LINU, PETS

Blue Horseshoe Stocks: Options, NLNK Recaps & More

GoPro, Inc. GPRO

We took advantage of the situation with GPRO yesterday after noticing the stock light up the boards in the premarket on the heels of a guidance adjustment.

We set our sights on the GPRO Weekly $9.50 & $10 Calls and both sets of contracts ended up providing traders with a chance at notable intraday gains.

The $9.50′s ran from .13-.90 for a whopping intraday pop of 592%, while the $10′s traded in a range from .47-1.20 for chances at up to 155% profit.



Insmed, Inc. INSM – Update

We’ve also got the pleasure of updating the figures on the options idea we put out on Tuesday after INSM had yet another solid session. The updated ranges on the contracts we selected are quite impressive, including a twelve-bagger, clearly demonstrating why we devote so much energy to options trading in addition to stocks!

The gains that were up for grabs to anyone who was paying attention were as follows:

$27 Calls
– Range: .95-4.50 – Max Gain: 373%
$28 Calls – Range:  .25-3.40 – Max Gain: 1260%
$29 Calls – Range: .40-2.75 – Max Gain: 588%
$30 Calls – Range: .50-2.12 – Max Gain: 324%


NewLink Genetics Corp. NLNK

We also had some very good fortune with our call of NLNK yesterday morning, which we caught notice of on our routine morning scan after some abnormal activity cropped up in the premarket.

Despite the fact that it went into the session as a $9+ stock, we still saw a really nice intraday push en route to NLNK going on the books as the NASDAQ’s top mover. We observed as the stock ran from a low of  9.50, traded up for essentially the entire session, and hit a high of 14.48 for a hefty 52% move on the day.

NLNK closed with strength, maintaining well over half its daily advance, so we’ll definitely want to continue to monitor the situation. No matter how you slice it, a single-session gain of 50% from a nearly ten-dollar stock, is nothing short of incredible.


Extended Watchlist:
CLDR, KURA, AVEO, OPGN, EPIX, FUTL,
FRTA(Bottom-Bouncer)

Blue Horseshoe Stocks: Options, News Play & More

Insmed, Inc. INSM – Options Review

We originally submitted our idea for the INSM options chain on Tuesday morning, tagging the INSM 09/15 $27-30 Calls on the heels of the company’s release of promising Phase-3 topline study results for its rare lung disease treatment.

Yesterday morning we updated our readers after the stock had made a marginal move which allowed for notable gains in just one of the four contracts in our observed range. However, we doubled down with our interest in these plays, mentioning that it seemed likely for the stock to provide a better chance at more sweeping gains and that’s just what happened.

The following moves were made yesterday afternoon which facilitated solid potential profits for anyone who was following along with the action. Those highly impressive gains were as follows:

$27 Calls – Range: .95-3.00 – Max Gain: 215%
$28 Calls – Range:  .25-2.00 – Max Gain: 700%
$29 Calls – Range: .40-1.60 – Max Gain: 300%
$30 Calls – Range: .50-1.55 – Max Gain: 210%
______

Fresh Ideas:
GoPro, Inc. GPRO – Weekly $9.50 & $10 Calls

Trivago N.V. TRVG – 10/20 $15 & 17.50 Calls


NXT-id, Inc. NXTD

We’re seeing a sizable gap-up taking place in the premarket this morning on NXTD. The big boost in activity is stemming from a huge news announcement published today concerning a deal the company struck with Bank of America to get its ‘FitPay’ contact-less device payment solutions installed in more than 9,000 Bank of America ATMs. (>>View PR)

With a blockbuster announcement such as this, we’re definitely going to want to observe the action as we head into week’s end and beyond.


Extended Watchlist:
CLNT, MNKD, PTN, IRT, COGT, ADAP, NLNK